A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The main purpose of this study is to evaluate the efficacy in reducing glycated hemoglobin of ipragliflozin in combination with metformin compared with metformin plus placebo in subjects with type 2 diabetes mellitus who have inadequate glycemic control on metformin.
Epistemonikos ID: 11a0999b036c9b705f27af66154dbe7292cc8083
First added on: May 17, 2024